TITLE

Prior aminosalicylate use and the development of colorectal cancer in inflammatory bowel disease (IBD): a large British epidemiological study

AUTHOR(S)
Staa, T P van; Card, T; Leufkens, H G M; Logan, R F
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS244
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article concerning epidemiological study on inflammatory bowel disease (IBD) in relation to development of colorectal cancer and aminosalicylate use is presented.
ACCESSION #
66954776

 

Related Articles

  • Colorectal Cancer in IBD Patients. Stormont, James M; Shah, Ashok N; Sharma, Anil K; Saubermann, Lawrence J; Farmer, Richard G // American Journal of Gastroenterology;Sep2013, Vol. 108 Issue 9, p1535 

    A letter to the editor is presented in response to the article regarding colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD).

  • Update on Colorectal Cancer. Rudy, David R.; Zdon, Michael J. // American Family Physician;3/15/2000, Vol. 61 Issue 6, p1759 

    Presents information on colorectal cancer in the United States. Incidence of colorectal cancer in 1999; Discussion on inflammatory bowel disease and colorectal cancer; Inherited colon cancer syndromes.

  • Editorial. Danese, Silvio // Current Drug Targets;May2008, Vol. 9 Issue 5, p360 

    The author reflects on the association between inflammation and the promotion of cancer. He notes that most epidemiological research have demonstrated that chronic inflammation predisposes people to certain cancers. He states that increased expression of genes linked with macrophage infiltration...

  • Response to Riyaz et al. Bernstein, Charles N.; Nugent, Zoann; Blanchard, James F. // American Journal of Gastroenterology;Sep2011, Vol. 106 Issue 9, p1721 

    A response by Charles N. Bernstein, Zoann Nugent, and James F. Blanchard to a letter to the editor about their article "5-Aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study" in the 2011 issue is presented.

  • Intestinal networks in health and disease. Weiss, Ulla // Nature;6/16/2011, Vol. 474 Issue 7351, p297 

    An introduction is presented in which the editor discusses various reports within the issue on topics on chronic inflammatory bowel disease, colorectal cancer and metabolic disease.

  • ADENOMATOUS POLYPS ARE RARE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Dixon, A.; Wurm, P.; Robinson, R.; Hart, A. // Gut;Apr2003 Supplement 1, Vol. 52, pA65 

    Objective: The prevalence of adenomatous colorectal polyps in inflammatory bowel disease (IBD) is unknown, although recent reports suggest they might be rare in patients with ulcerative colitis (UC). Previous work has suggested 5-ASA compounds may protect against colorectal cancer. The aim of...

  • Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Lutgens, M. W. M. D.; Oldenburg, B.; Siersema, P. D.; van Bodegraven, A. A.; Dijkstra, G.; Hommes, D. W.; de Jong, D. J.; Stokkers, P. C. F.; van der Woude, C. J.; Vleggaar, F. P. // British Journal of Cancer;11/17/2009, Vol. 101 Issue 10, p1671 

    Background:Colonoscopic surveillance provides the best practical means for preventing colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients. Strong evidence for improved survival from surveillance programmes is sparse.Method:The aim of this study was to compare tumour stage and...

  • Susceptibility of three different immunodeficient mouse strains in Helicobacter hepaticus-induced typhlocolitis and lower bowel cancer. Poutahidis, T.; Erdman, S.E.; Horwitz, B.; Rogers, A.B.; Fox, J.G. // Gut;Sep2002 Supplement 2, Vol. 51, pA53 

    Human inflammatory bowel disease (IBD) is a significant health problem and predisposes to colorectal cancer. Several immune dysregulated murine models have highlighted the role of genetic and environmental factors in the pathogenesis of colitis. Studies have also cited the importance of abnormal...

  • Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Balzola, Federico; Bernstein, Charles; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2011, Vol. 12 Issue 2, p75 

    The article presents a study which examines the clinical characteristics and treatment in inflammatory bowel disease (IBD) patients having colorectal cancer (CRC) in Ireland. The study showed that CRC and IBD patients were a mean of 7.7 years younger compared to those without IBD at CRC...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics